Goldline Pharmaceutical Limited (BOM:544759)
India flag India · Delayed Price · Currency is INR
29.60
+0.33 (1.13%)
At close: Nov 16, 2026

Goldline Pharmaceutical Revenue

Goldline Pharmaceutical had revenue of 74.63M INR in the quarter ending September 30, 2026. In the fiscal year ending March 31, 2026, Goldline Pharmaceutical had annual revenue of 311.98M with 11.20% growth. That makes Goldline Pharmaceutical the 41,233rd largest company in the world by revenue and 4,107th in India.

Revenue
311.98M
Revenue Growth
+11.20%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
126
Market Cap
284.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026311.98M31.42M11.20%
Mar 31, 2025280.56M44.90M19.05%
Mar 31, 2024235.66M37.18M18.73%
Mar 31, 2023198.48M-41.62M-17.33%
Mar 31, 2022240.11M21.15M9.66%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.